foxo4 dri senolytic mechanism Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis FOXO4-DRI: The Senolytic Peptide That

Annals of the New York Academy of Sciences

Lower concentrations reduce injection volume but require more frequent refrigerator access, increasing temperature fluctuation risk

Always consult a licensed healthcare provider before beginning therapy

Top contenders are BPC-157 for repair and inflammation control, Thymosin Beta-4 for cell migration and anti-fibrosis, GHK-Cu for collagen production and antioxidant support, and Kisspeptin and Gonadorelin for hormonal regulation

PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 78 H 123 N 23 O 23 S 2 Weight: 1815.12 g/mol Origin: HGH Fragment 176-191 + Tyrosine Structure: Modified peptide with disulfide bridge PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Readily soluble in water Stability: Excellent with disulfide bridge Storage: Keep refrigerated 3646 F (28 C) Related products CJC-1295 $60.00 $95.00Price range: $60.00 through $95.00 TB-500 $60.00 $90.00Price range: $60.00 through $90.00